-
Je něco špatně v tomto záznamu ?
Prasugrel monotherapy versus standard DAPT in STEMI patients with OCT-guided or angio-guided complete revascularisation: design and rationale of the randomised, multifactorial COMPARE STEMI ONE trial
V. Paradies, NM. Van Mieghem, RM. Oemrawsingh, G. Richardt, G. Esposito, G. Campo, F. Burzotta, P. Canova, A. Linke, I. Porto, D. Trabattoni, K. Teeuwen, T. Adriaenssens, P. Kala, G. Stankovic, RV. Vliet, D. Giacoppo, J. Daemen, PC. Smits
Jazyk angličtina Země Francie
Typ dokumentu časopisecké články, protokol klinické studie, randomizované kontrolované studie, multicentrická studie, srovnávací studie
PubMed
40375771
DOI
10.4244/eij-d-24-00829
Knihovny.cz E-zdroje
- MeSH
- antagonisté purinergních receptorů P2Y * terapeutické užití MeSH
- infarkt myokardu s elevacemi ST úseků * terapie farmakoterapie diagnostické zobrazování chirurgie MeSH
- inhibitory agregace trombocytů * terapeutické užití MeSH
- koronární angiografie metody MeSH
- koronární angioplastika * metody MeSH
- lidé MeSH
- optická koherentní tomografie * metody MeSH
- prasugrel hydrochlorid * terapeutické užití MeSH
- randomizované kontrolované studie jako téma MeSH
- výsledek terapie MeSH
- Check Tag
- lidé MeSH
- mužské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- multicentrická studie MeSH
- protokol klinické studie MeSH
- randomizované kontrolované studie MeSH
- srovnávací studie MeSH
Monotherapy with a potent P2Y12 receptor antagonist after 1 month of dual antiplatelet therapy (DAPT) may reduce bleeding in the absence of increased ischaemic events compared to 12-month DAPT in patients with acute coronary syndrome undergoing percutaneous coronary intervention (PCI). PCI guidance with optical coherence tomography (OCT) may enhance stent expansion. COMPARE STEMI ONE is an international, multicentre, open-label, randomised controlled trial. In 1,656 ST-segment elevation myocardial infarction (STEMI) patients, prasugrel monotherapy after 1 month of DAPT, as compared to standard 12-month prasugrel-based DAPT, will be tested for non-inferiority for the primary composite endpoint of net adverse clinical events - defined as all-cause death, myocardial infarction, stroke, or Bleeding Academic Research Consortium Type 3 or 5 bleeding events - at 11 months after randomisation. Furthermore, an ancillary substudy will test the superiority of OCT-guided versus angiography-guided staged complete revascularisation in achieving a larger minimal stent area (MSA) in non-culprit lesions during staged procedures. COMPARE STEMI ONE is the first randomised controlled trial assessing an abbreviated 1-month DAPT regimen followed by prasugrel monotherapy in the context of STEMI. The trial will also study the value of OCT-guided PCI in terms of the MSA of non-culprit lesions and may elucidate potential synergies between intravascular imaging-guided PCI and abbreviated DAPT regimens. (ClinicalTrials.gov: NCT05491200).
Cardiology Department Catharina Hospital Eindhoven the Netherlands
Cardiology Department Heart Center Dresden University Dresden Germany
Cardiology Unit Azienda Ospedaliero Univesitaria di Ferrara Cona Italy
Cardiovascular Disease Unit IRCCS Ospedale Policlinico San Martino Genoa Italy
Department of Advanced Biomedical Sciences University of Naples Federico 2 Naples Italy
Department of Cardiology Amphia Hospital Breda the Netherlands
Department of Cardiology Asklepios Klinik Bad Oldesloe Bad Oldesloe Germany
Department of Cardiology Maasstad Hospital Rotterdam the Netherlands
Department of General Surgery and Surgical Medical Specialties University of Catania Catania Italy
Department of Interventional Cardiology Centro Cardiologico Monzino IRCCS Milan Italy
Fondazione Policlinico Universitario A Gemelli IRCCS Università Cattolica del Sacro Cuore Rome Italy
ISAResearch Zentrum German Heart Center Munich Germany
Ospedale Papa Giovanni XXIII Bergamo Italy
The University Hospital Brno Medical Faculty of Masaryk University Brno Czech Republic
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc25015726
- 003
- CZ-PrNML
- 005
- 20250731091204.0
- 007
- ta
- 008
- 250708s2025 fr f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.4244/EIJ-D-24-00829 $2 doi
- 035 __
- $a (PubMed)40375771
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a fr
- 100 1_
- $a Paradies, Valeria $u Department of Cardiology, Maasstad Hospital, Rotterdam, the Netherlands $u Department of Cardiology, Cardiovascular Institute, Thoraxcenter, Erasmus University Medical Center, Rotterdam, the Netherlands
- 245 10
- $a Prasugrel monotherapy versus standard DAPT in STEMI patients with OCT-guided or angio-guided complete revascularisation: design and rationale of the randomised, multifactorial COMPARE STEMI ONE trial / $c V. Paradies, NM. Van Mieghem, RM. Oemrawsingh, G. Richardt, G. Esposito, G. Campo, F. Burzotta, P. Canova, A. Linke, I. Porto, D. Trabattoni, K. Teeuwen, T. Adriaenssens, P. Kala, G. Stankovic, RV. Vliet, D. Giacoppo, J. Daemen, PC. Smits
- 520 9_
- $a Monotherapy with a potent P2Y12 receptor antagonist after 1 month of dual antiplatelet therapy (DAPT) may reduce bleeding in the absence of increased ischaemic events compared to 12-month DAPT in patients with acute coronary syndrome undergoing percutaneous coronary intervention (PCI). PCI guidance with optical coherence tomography (OCT) may enhance stent expansion. COMPARE STEMI ONE is an international, multicentre, open-label, randomised controlled trial. In 1,656 ST-segment elevation myocardial infarction (STEMI) patients, prasugrel monotherapy after 1 month of DAPT, as compared to standard 12-month prasugrel-based DAPT, will be tested for non-inferiority for the primary composite endpoint of net adverse clinical events - defined as all-cause death, myocardial infarction, stroke, or Bleeding Academic Research Consortium Type 3 or 5 bleeding events - at 11 months after randomisation. Furthermore, an ancillary substudy will test the superiority of OCT-guided versus angiography-guided staged complete revascularisation in achieving a larger minimal stent area (MSA) in non-culprit lesions during staged procedures. COMPARE STEMI ONE is the first randomised controlled trial assessing an abbreviated 1-month DAPT regimen followed by prasugrel monotherapy in the context of STEMI. The trial will also study the value of OCT-guided PCI in terms of the MSA of non-culprit lesions and may elucidate potential synergies between intravascular imaging-guided PCI and abbreviated DAPT regimens. (ClinicalTrials.gov: NCT05491200).
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a prasugrel hydrochlorid $x terapeutické užití $7 D000068799
- 650 12
- $a infarkt myokardu s elevacemi ST úseků $x terapie $x farmakoterapie $x diagnostické zobrazování $x chirurgie $7 D000072657
- 650 12
- $a optická koherentní tomografie $x metody $7 D041623
- 650 12
- $a koronární angioplastika $x metody $7 D062645
- 650 12
- $a inhibitory agregace trombocytů $x terapeutické užití $7 D010975
- 650 _2
- $a výsledek terapie $7 D016896
- 650 _2
- $a koronární angiografie $x metody $7 D017023
- 650 12
- $a antagonisté purinergních receptorů P2Y $x terapeutické užití $7 D058921
- 650 _2
- $a randomizované kontrolované studie jako téma $7 D016032
- 650 _2
- $a mužské pohlaví $7 D008297
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a protokol klinické studie $7 D000078325
- 655 _2
- $a randomizované kontrolované studie $7 D016449
- 655 _2
- $a multicentrická studie $7 D016448
- 655 _2
- $a srovnávací studie $7 D003160
- 700 1_
- $a Van Mieghem, Nicolas M $u Department of Cardiology, Cardiovascular Institute, Thoraxcenter, Erasmus University Medical Center, Rotterdam, the Netherlands
- 700 1_
- $a Oemrawsingh, Rohit M $u Department of Cardiology, Amphia Hospital, Breda, the Netherlands
- 700 1_
- $a Richardt, Gert $u Department of Cardiology, Asklepios Klinik Bad Oldesloe, Bad Oldesloe, Germany
- 700 1_
- $a Esposito, Giovanni $u Department of Advanced Biomedical Sciences, University of Naples "Federico II, Naples, Italy
- 700 1_
- $a Campo, Gianluca $u Cardiology Unit, Azienda Ospedaliero Univesitaria di Ferrara, Cona (FE), Italy
- 700 1_
- $a Burzotta, Francesco $u Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy
- 700 1_
- $a Canova, Paolo $u Ospedale Papa Giovanni XXIII, Bergamo, Italy
- 700 1_
- $a Linke, Axel $u Cardiology Department, Heart Center Dresden University, Dresden, Germany
- 700 1_
- $a Porto, Italo $u Cardiovascular Disease Unit, IRCCS Ospedale Policlinico San Martino, Genoa, Italy
- 700 1_
- $a Trabattoni, Daniela $u Department of Interventional Cardiology, Centro Cardiologico Monzino, IRCCS, Milan, Italy
- 700 1_
- $a Teeuwen, Koen $u Cardiology Department, Catharina Hospital, Eindhoven, the Netherlands
- 700 1_
- $a Adriaenssens, Tom $u Department of Cardiovascular Medicine, University Hospitals Leuven, Leuven, Belgium and Department of Cardiovascular Sciences, Katholieke Universiteit Leuven, Leuven, Belgium
- 700 1_
- $a Kala, Petr $u The University Hospital Brno, Medical Faculty of Masaryk University, Brno, Czech Republic
- 700 1_
- $a Stankovic, Goran $u Department of Cardiology, University Clinical Center of Serbia, Belgrade, Serbia and Faculty of Medicine, University of Belgrade, Belgrade, Serbia
- 700 1_
- $a Vliet, Ria van $u Department of Cardiology, Maasstad Hospital, Rotterdam, the Netherlands
- 700 1_
- $a Giacoppo, Daniele $u Department of General Surgery and Surgical-Medical Specialties, University of Catania, Catania, Italy $u Cardiovascular Research Institute, Mater Private Hospital, Royal College of Surgeons in Ireland, Dublin, Ireland $u ISAResearch Zentrum, German Heart Center, Munich, Germany
- 700 1_
- $a Daemen, Joost $u Department of Cardiology, Cardiovascular Institute, Thoraxcenter, Erasmus University Medical Center, Rotterdam, the Netherlands
- 700 1_
- $a Smits, Pieter C $u Department of Cardiology, Maasstad Hospital, Rotterdam, the Netherlands
- 773 0_
- $w MED00184784 $t EuroIntervention $x 1969-6213 $g Roč. 21, č. 10 (2025), s. 571-580
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/40375771 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20250708 $b ABA008
- 991 __
- $a 20250731091159 $b ABA008
- 999 __
- $a ok $b bmc $g 2366521 $s 1252851
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2025 $b 21 $c 10 $d 571-580 $e 20250516 $i 1969-6213 $m EuroIntervention $n EuroIntervention $x MED00184784
- LZP __
- $a Pubmed-20250708
